New studies suggest that GLP-1 weight-loss drugs like Ozempic and Mounjaro may help reduce cancer progression and recurrence in certain patients. Researchers observed improved survival rates and lower tumour growth in breast, lung, colorectal and liver cancers, although experts say more clinical trials are needed before confirming their role in cancer treatment.
